XML 226 R17.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Fair Value Measurements | 12 Months Ended
--- | ---
Dec. 31, 2023
Fair Value Disclosures [Abstract] |
Fair Value Measurements | Note 9 Fair Value Measurements The tables below show the fair value hierarchy for assets and liabilities measured at fair value on a recurring and nonrecurring basis at December 31, 2023 and 2022. Marketable Securities The company calculates fair value for its marketable securities based on quoted market prices for identical assets. The fair values reflect the cash that would have been received if the instruments were sold at December 31, 2023. Derivatives The company records most of its derivative instruments – other than any commodity derivative contracts that are accounted for as normal purchase and normal sale – on the Consolidated Balance Sheet at fair value, with the offsetting amount to the Consolidated Statement of Income. The company designates certain derivative instruments as cash flow hedges that, if applicable, are reflected in the table below. Derivatives classified as Level 1 include futures, swaps and options contracts valued using quoted prices from active markets such as the New York Mercantile Exchange. Derivatives classified as Level 2 include swaps, options and forward contracts, the fair values of which are obtained from third-party broker quotes, industry pricing services and exchanges. The company obtains multiple sources of pricing information for the Level 2 instruments. Since this pricing information is generated from observable market data, it has historically been very consistent. The company does not materially adjust this information. Properties, Plant and Equipment In 2023, the company impaired a portion of its U.S. upstream assets, primarily in California, due to continuing regulatory challenges in the state that have resulted in lower anticipated future investment levels in its business plans. The company did not have any individually material impairments of long-lived assets measured at fair value on a nonrecurring basis to report in 2022. Investments and Advances The company did not have any material impairments of investments and advances measured at fair value on a nonrecurring basis to report in 2023 or 2022. Assets and Liabilities Measured at Fair Value on a Recurring Basis
|  | At December 31, 2023 |  |  | At December 31, 2022 |
|  | Total |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
Marketable securities |  | $ | 45 |  |  | $ | 45 |  |  | $ | — |  |  | $ | — |  |  | $ | 223 |  |  | $ | 223 |  |  | $ | — |  |  | $ | — |
Derivatives - not designated |  |  | 152 |  |  |  | 24 |  |  |  | 128 |  |  |  | — |  |  |  | 184 |  |  |  | 111 |  |  |  | 73 |  |  |  | — |
Derivatives - designated |  |  | 7 |  |  |  | 7 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Total assets at fair value |  | $ | 204 |  |  | $ | 76 |  |  | $ | 128 |  |  | $ | — |  |  | $ | 407 |  |  | $ | 334 |  |  | $ | 73 |  |  | $ | — |
Derivatives - not designated |  |  | 262 |  |  |  | 160 |  |  |  | 102 |  |  |  | — |  |  |  | 43 |  |  |  | 33 |  |  |  | 10 |  |  |  | — |
Derivatives - designated |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 15 |  |  |  | 15 |  |  |  | — |  |  |  | — |
Total liabilities at fair value |  | $ | 262 |  |  | $ | 160 |  |  | $ | 102 |  |  | $ | — |  |  | $ | 58 |  |  | $ | 48 |  |  | $ | 10 |  |  | $ | — |
Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis
|  | At December 31 |  |  | At December 31 |
|  | Total |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Before-Tax Loss Year 2023 |  |  | Total |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Before-Tax Loss Year 2022 |
Properties, plant and equipment, net (held and used) |  | $ | 484 |  |  | $ | — |  |  | $ | — |  |  | $ | 484 |  |  | $ | 2,175 |  |  | $ | 54 |  |  | $ | — |  |  | $ | — |  |  | $ | 54 |  |  | $ | 518 |
Properties, plant and equipment, net (held for sale) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 5 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 432 |
Investments and advances |  |  | 207 |  |  |  | 5 |  |  |  | 165 |  |  |  | 37 |  |  |  | 352 |  |  |  | 33 |  |  |  | 2 |  |  |  | — |  |  |  | 31 |  |  |  | 9 |
Total nonrecurring assets at fair value |  | $ | 691 |  |  | $ | 5 |  |  | $ | 165 |  |  | $ | 521 |  |  | $ | 2,532 |  |  | $ | 87 |  |  | $ | 2 |  |  | $ | — |  |  | $ | 85 |  |  | $ | 959 |
At year-end 2023, the company had assets measured at fair value Level 3 using unobservable inputs of $521. The carrying value of these assets were written down to fair value based on estimates derived from discounted cash flow models. Cash flows were determined using estimates of future production, an outlook of future price based on published prices and a discount rate believed to be consistent with those used by principal market participants. Assets and Liabilities Not Required to Be Measured at Fair Value The company holds cash equivalents in U.S. and non-U.S. portfolios. The instruments classified as cash equivalents are primarily bank time deposits with maturities of 90 days or less and money market funds. “Cash and cash equivalents” had carrying/fair values of $8,178 and $17,678 at December 31, 2023, and December 31, 2022, respectively. The fair values of cash and cash equivalents are classified as Level 1 and reflect the cash that would have been received if the instruments were settled at December 31, 2023. “Cash and cash equivalents” do not include investments with a carrying/fair value of $1,097 and $1,443 at December 31, 2023, and December 31, 2022, respectively. At December 31, 2023, these investments are classified as Level 1 and include restricted funds related to certain upstream decommissioning activities, a financing program and tax payments. Long-term debt, excluding finance lease liabilities, of $14,612 and $16,258 at December 31, 2023, and December 31, 2022, respectively, had estimated fair values of $13,709 and $14,959, respectively. Long-term debt primarily includes corporate issued bonds. The fair value of corporate bonds is $13,321 and classified as Level 1. The fair value of other long-term debt classified as Level 2 is $388. The carrying values of other short-term financial assets and liabilities on the Consolidated Balance Sheet approximate their fair values. Fair value remeasurements of other financial instruments at December 31, 2023 and 2022, were not material.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration